SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
October 14, 1996
SPECIALIZED HEALTH PRODUCTS INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
0-26694 93-0945003
(Commission file number) (IRS employer identification no.)
655 East Medical Drive, Bountiful, Utah 84010
(Address of principal executive offices) (Zip code)
(801) 298-3360
(Registrant's telephone number, including area code)
This document contains a total of 5 pages.
<PAGE>
Item 4. Changes in and Disagreements With Accountants on Accounting and
Financial Disclosure.
On October 14, 1996, the Registrant's Board of Directors elected to retain
Arthur Andersen LLP ("AA") as its independent auditor and to dismiss KPMG Peat
Marwick LLP ("KPMG"). Heretofore KPMG had acted as the Registrant's independent
auditor. The decision to change auditors was recommended by the Registrant's
Board of Directors.
The reports of KPMG on the financial statements of the Registrant for
each of the two fiscal years in the period ended December 31, 1995, did not
contain any adverse opinion or disclaimer of opinion and were not qualified or
modified as to uncertainty, audit scope or accounting principles.
During the Registrant's two most recent fiscal years and all subsequent
interim periods preceding such change in auditors, there was no disagreement
with KPMG on any matter of accounting principles or practices, financial
statement disclosure, or auditing scope or procedure, which, if not resolved to
the satisfaction of the former accountant, would have caused it to make a
reference to the subject matter of the disagreements in connection with its
report; nor has KPMG ever presented a written report, or otherwise communicated
in writing to the Registrant or its Board of Directors the existence of any
"disagreement" or "reportable event" within the meaning of Item 304 of
Regulation S-K.
The Registrant has authorized KPMG to respond fully to the inquiries of
the Registrant's successor accountant and has requested that KPMG provide the
Registrant with a letter addressed to the SEC, as required by Item 304(a)(3) of
Regulations S-K, so that the Registrant can file such letter with the SEC.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
a. Financial Statements of Businesses Acquired.
Not applicable.
b. Pro Forma Financial Information.
Not applicable.
c. Exhibits.
Number Description
16 Letter re change in certifying accountant
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SPECIALIZED HEALTH PRODUCTS
INTERNATIONAL, INC.
Date: October 17, 1996 By /s/ David A. Robinson
David A. Robinson
President, Chief Executive Officer
and Director
<PAGE>
KPMG Peat Marwick LLP
60 East South Temple
Suite 900
Salt Lake City, UT 84111
October 15, 1996
Securities and Exchange Commission
Washington, D.C. 20549
Ladies and Gentlemen:
We were previously principal accountants for Specialized Health Products
International, Inc. and under the date of February 2, 1996, we reported on the
consolidated financial statements of Specialized Health Products International,
Inc. and subsidiary as of and for the years ended December 31, 1995 and 1994,
and for the period from November 19, 1993 (date of inception) to December 31,
1993. On October 14, 1996, our appointment as principal accountants was
terminated. We have read Specialized Health Products International, Inc.'s
statements included under item 4 of its Form 8-K dated October 14, 1996, and we
agree with such statements, except that we are not in a position to agree or
disagree with Specialized Health Products International, Inc.'s statement that
the change was recommended by the Board of Directors.
Very truly yours,
/s/ KPMG Peat Marwick LLP
